title: Diagnosis and management of poor neonatal adaptation syndrome in newborns exposed in utero to selective seretonin/norepinephrine reuptake inhibitors.
authors.affiliation: The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto, ON.
authors.forename: Gideon
authors.initials: G
authors.lastname: Koren
authors.affiliation: The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto, ON.
authors.forename: Yaron
authors.initials: Y
authors.lastname: Finkelstein
authors.affiliation: Department of Pediatrics, Univeristy of Western Ontario, London ON.
authors.forename: Doreen
authors.initials: D
authors.lastname: Matsui
authors.affiliation: Department of Pediatrics, Assaf Harofe Hospital, Tel Aviv University, Tel Aviv, Israel.
authors.forename: Matitiahu
authors.initials: M
authors.lastname: Berkovich
mesh_terms: D003863:Depression / Q000188:drug therapy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D009357:Neonatal Abstinence Syndrome / Q000175:diagnosis* / Q000628:therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D017367:Selective Serotonin Reuptake Inhibitors